Home › Funds › ExodusPoint Capital Management, LP › HAE
ExodusPoint Capital Management, LP position in HAE
HAEMONETICS CORP MASS · Health Care
ExodusPoint Capital Management, LP reported holding 563,064 shares of HAE (HAEMONETICS CORP MASS) in its Q3 2026 13F filing — a position valued at US$59.3M, representing 0.50% of its reported portfolio and ranking #22 among its reported holdings. ExodusPoint Capital Management, LP has disclosed HAE holdings in 9 of the last 10 reported quarters, going back to Q2 2024.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How ExodusPoint Capital Management, LP's HAE position evolved
ExodusPoint Capital Management, LP first disclosed a stake in HAE in Q2 2024 at 29,276 shares (US$2.4M). The position peaked in Q3 2026 at 563,064 shares, worth US$59.3M. Across 9 filings, ExodusPoint Capital Management, LP increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 563,064 shares valued at US$59.3M. Notable position changes include a 176% increase in Q3 2024 (shares fell 3% over the following quarter), a 345% increase in Q1 2025 (shares rose 17% over the following quarter), a 146% increase in Q3 2025 (shares rose 64% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 29.28K | $2.42M | New |
| Q3 2024 | 80.94K | $6.51M | Add |
| Q4 2024 | 14.44K | $1.13M | Reduce |
| Q1 2025 | 64.34K | $4.09M | Add |
| Q2 2025 | 126.52K | $9.44M | Add |
| Q3 2025 | 311.85K | $15.20M | Add |
| Q4 2025 | 96.32K | $7.72M | Reduce |
| Q1 2026 | 47.75K | $2.69M | Reduce |
| Q3 2026 | 563.06K | $59.29M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About HAE and 13F data
HAE (HAEMONETICS CORP MASS) is a Health Care company. 24 other funds we track also report a position in HAE — the largest reported positions include ARIEL INVESTMENTS, LLC (US$228.9M), River Road Asset Management, LLC (US$110.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding HAE
- ARIEL INVESTMENTS, LLC 2.17M sh · $228.88M · Q3 2026
- River Road Asset Management, LLC 1.05M sh · $110.08M · Q3 2026
More on ExodusPoint Capital Management, LP
FAQ
How long has ExodusPoint Capital Management, LP held HAE?
ExodusPoint Capital Management, LP has disclosed HAE holdings in 9 of the last 10 reported quarters, going back to Q2 2024.
What is ExodusPoint Capital Management, LP's current position in HAE?
As of Q3 2026, ExodusPoint Capital Management, LP holds 563.06K shares of HAE (HAEMONETICS CORP MASS), valued at $59.29M, representing 0.50% of its reported portfolio and ranking #22.
Has ExodusPoint Capital Management, LP been buying or selling HAE?
In the latest 13F filing (Q3 2026), ExodusPoint Capital Management, LP newly opened its position in HAE. The position peaked in Q3 2026 at 563.06K shares.
Which other funds hold HAE?
Other major institutional holders of HAE include ARIEL INVESTMENTS, LLC, River Road Asset Management, LLC, among 24 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.